Jovan Mircetic

437 total citations
14 papers, 257 citations indexed

About

Jovan Mircetic is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jovan Mircetic has authored 14 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Jovan Mircetic's work include CRISPR and Genetic Engineering (7 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Research and Splicing (3 papers). Jovan Mircetic is often cited by papers focused on CRISPR and Genetic Engineering (7 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Research and Splicing (3 papers). Jovan Mircetic collaborates with scholars based in Germany, Denmark and Netherlands. Jovan Mircetic's co-authors include Frank Buchholz, Maciej Paszkowski‐Rogacz, Duran Sürün, Katrin Neumann, Min Ae Lee‐Kirsch, Debojyoti Chakraborty, Li Ding, Mirko Theis, Daniel E. Stange and Olga Alexandra Sidorova and has published in prestigious journals such as Nature Communications, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Jovan Mircetic

13 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jovan Mircetic Germany	9	219	57	45	42	24	14	257
Marta Martínez-Lage Spain	7	246 1.1×	72 1.3×	50 1.1×	41 1.0×	11 0.5×	8	292
Changchang Xin China	8	339 1.5×	56 1.0×	35 0.8×	33 0.8×	18 0.8×	14	374
Paul C. Kirchgatterer United States	3	452 2.1×	65 1.1×	43 1.0×	29 0.7×	18 0.8×	4	502
Chenqiang Jia China	7	252 1.2×	47 0.8×	51 1.1×	22 0.5×	10 0.4×	9	301
Christopher R. Cromwell Canada	8	276 1.3×	40 0.7×	33 0.7×	24 0.6×	19 0.8×	15	310
GaHyun Lee United States	5	244 1.1×	52 0.9×	26 0.6×	20 0.5×	21 0.9×	8	264
Marion Piganeau France	5	474 2.2×	95 1.7×	69 1.5×	61 1.5×	16 0.7×	6	506
Tomasz Kallas Sweden	7	436 2.0×	75 1.3×	38 0.8×	36 0.9×	23 1.0×	8	481
Emil Aagaard Thomsen Denmark	10	249 1.1×	72 1.3×	55 1.2×	23 0.5×	9 0.4×	21	305
Vidit Bhandarkar United States	4	283 1.3×	50 0.9×	83 1.8×	9 0.2×	21 0.9×	4	363

Countries citing papers authored by Jovan Mircetic

Since Specialization

Citations

This map shows the geographic impact of Jovan Mircetic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jovan Mircetic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jovan Mircetic more than expected).

Fields of papers citing papers by Jovan Mircetic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jovan Mircetic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jovan Mircetic. The network helps show where Jovan Mircetic may publish in the future.

Co-authorship network of co-authors of Jovan Mircetic

This figure shows the co-authorship network connecting the top 25 collaborators of Jovan Mircetic. A scholar is included among the top collaborators of Jovan Mircetic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jovan Mircetic. Jovan Mircetic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Peitzsch, Mirko, et al.. (2025). A novel role of exostosin glycosyltransferase 2 (EXT2) in glioblastoma cell metabolism, radiosensitivity and ferroptosis. Cell Death and Differentiation. 32(9). 1664–1678. 2 indexed citations

Es, Johan H. van, Cornelia Brunner, Jovan Mircetic, et al.. (2024). Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome. Molecular Cancer. 23(1). 39–39. 9 indexed citations

Mircetic, Jovan, Li Ding, Maciej Paszkowski‐Rogacz, et al.. (2023). CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability. Small Methods. 7(6). e2201605–e2201605. 21 indexed citations

Sidorova, Olga Alexandra, Alexander Hennig, Martina Augsburg, et al.. (2022). Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing. Cancer Research. 82(17). 3002–3015. 28 indexed citations

Sürün, Duran, et al.. (2022). Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines. Methods in molecular biology. 2508. 235–260. 1 indexed citations

Ding, Li, Lukas Theo Schmitt, Melanie Brux, et al.. (2022). DNA methylation–independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins. Life Science Alliance. 5(6). e202101321–e202101321. 5 indexed citations

Ding, Li, Maciej Paszkowski‐Rogacz, Jovan Mircetic, Debojyoti Chakraborty, & Frank Buchholz. (2020). The Paf1 complex positively regulates enhancer activity in mouse embryonic stem cells. Life Science Alliance. 4(3). e202000792–e202000792. 12 indexed citations

Sürün, Duran, Jovan Mircetic, Katrin Neumann, et al.. (2020). Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors. Genes. 11(5). 511–511. 93 indexed citations

Chakraborty, Debojyoti, Maciej Paszkowski‐Rogacz, Li Ding, et al.. (2018). LncRNA <i>Panct1</i> Maintains Mouse Embryonic Stem Cell Identity by Regulating TOBF1 Recruitment to Oct-Sox Sequences in Early G1. SSRN Electronic Journal.

10.

Chakraborty, Debojyoti, Maciej Paszkowski‐Rogacz, Li Ding, et al.. (2017). lncRNA Panct1 Maintains Mouse Embryonic Stem Cell Identity by Regulating TOBF1 Recruitment to Oct-Sox Sequences in Early G1. Cell Reports. 21(11). 3012–3021. 23 indexed citations

11.

Mircetic, Jovan, Antje Dietrich, Maciej Paszkowski‐Rogacz, Mechthild Krause, & Frank Buchholz. (2017). Development of a genetic sensor that eliminates p53 deficient cells. Nature Communications. 8(1). 15 indexed citations

12.

Mircetic, Jovan, Iris Steinebrunner, Li Ding, et al.. (2017). Purified Cas9 Fusion Proteins for Advanced Genome Manipulation. Small Methods. 1(4). 11 indexed citations

13.

Lohoff, Tim, Maciej Paszkowski‐Rogacz, Jovan Mircetic, et al.. (2016). Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. JNCI Journal of the National Cancer Institute. 109(1). 31 indexed citations

14.

Branković, Ana, Goran Brajušković, Jovan Mircetic, et al.. (2013). Common Variants at 8q24 are Associated with Prostate Cancer Risk in Serbian Population. Pathology & Oncology Research. 19(3). 559–569. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact